Arcus Biosciences (NYSE:RCUS) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:10 PM.
Here's what investors need to know about the announcement.
Earnings
Arcus Biosciences beat estimated earnings by 601.35%, reporting an EPS of $3.71 versus an estimate of $-0.74.
Revenue was up $345.01 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 11.97% increase in the share price the next day.
Here's a look at Arcus Biosciences's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -1.08 | -0.88 | -0.84 | -0.75 |
| EPS Actual | -1.11 | -1.09 | -1.08 | -0.82 |
| Revenue Estimate | 9.40M | 13.05M | 13.34M | 7.93M |
| Revenue Actual | 9.46M | 9.46M | 9.46M | 9.49M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
